Andy Vinter

552 total citations
7 papers, 444 citations indexed

About

Andy Vinter is a scholar working on Molecular Biology, Computational Theory and Mathematics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Andy Vinter has authored 7 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Computational Theory and Mathematics and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Andy Vinter's work include Computational Drug Discovery Methods (4 papers), Hormonal Regulation and Hypertension (3 papers) and vaccines and immunoinformatics approaches (1 paper). Andy Vinter is often cited by papers focused on Computational Drug Discovery Methods (4 papers), Hormonal Regulation and Hypertension (3 papers) and vaccines and immunoinformatics approaches (1 paper). Andy Vinter collaborates with scholars based in United Kingdom. Andy Vinter's co-authors include Mark Mackey, Sally Rose, Jonathan R. Seckl, Scott P. Webster, Brian R. Walker, Karen Sooy, Peter Ward, Margaret Binnie, Eilidh Craigie and Michael F. Greaney and has published in prestigious journals such as Chemical Communications, Journal of Chemical Information and Modeling and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Andy Vinter

7 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andy Vinter United Kingdom	5	233	155	105	60	47	7	444
Sally Rose United Kingdom	8	292 1.3×	172 1.1×	93 0.9×	50 0.8×	56 1.2×	12	510
Patrik Johansson Sweden	15	409 1.8×	113 0.7×	130 1.2×	141 2.4×	55 1.2×	20	641
Roberto Nuti Italy	11	304 1.3×	168 1.1×	93 0.9×	64 1.1×	19 0.4×	16	628
Sanna Niinivehmas Finland	13	286 1.2×	205 1.3×	123 1.2×	74 1.2×	36 0.8×	22	517
Bernd Wellenzohn Austria	18	534 2.3×	127 0.8×	100 1.0×	85 1.4×	37 0.8×	38	741
David Machalz Germany	10	214 0.9×	139 0.9×	49 0.5×	38 0.6×	22 0.5×	15	381
Chayan Acharya United States	11	330 1.4×	146 0.9×	53 0.5×	62 1.0×	34 0.7×	16	611
Andreas Luttens Sweden	7	275 1.2×	204 1.3×	65 0.6×	39 0.7×	49 1.0×	7	414
Olivier Corminboeuf Switzerland	16	231 1.0×	82 0.5×	349 3.3×	55 0.9×	18 0.4×	24	666
Jingxuan Zhu China	12	309 1.3×	69 0.4×	42 0.4×	20 0.3×	35 0.7×	27	513

Countries citing papers authored by Andy Vinter

Since Specialization

Citations

This map shows the geographic impact of Andy Vinter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Vinter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Vinter more than expected).

Fields of papers citing papers by Andy Vinter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Vinter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Vinter. The network helps show where Andy Vinter may publish in the future.

Co-authorship network of co-authors of Andy Vinter

This figure shows the co-authorship network connecting the top 25 collaborators of Andy Vinter. A scholar is included among the top collaborators of Andy Vinter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andy Vinter. Andy Vinter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Webster, Scott P., Margaret Binnie, Karen Sooy, et al.. (2010). Modulation of 11β-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazoles. Bioorganic & Medicinal Chemistry Letters. 20(11). 3265–3271. 22 indexed citations

2.

Baker, James R., et al.. (2010). An efficient asymmetric synthesis of the potent β-blocker ICI-118,551 allows the determination of enantiomer dependency on biological activity. Chemical Communications. 46(22). 3953–3953. 2 indexed citations

3.

Mackey, Mark, et al.. (2008). Rapid discovery of new leads for difficult targets: application to CCK2 and 11beta-HSD1. Chemistry Central Journal. 2(S1). 1 indexed citations

4.

Mackey, Mark, et al.. (2007). Molecular field technology applied to virtual screening and finding the bioactive conformation. Expert Opinion on Drug Discovery. 2(1). 131–144. 59 indexed citations

5.

Webster, Scott P., Peter Ward, Margaret Binnie, et al.. (2007). Discovery and biological evaluation of adamantyl amide 11β-HSD1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(10). 2838–2843. 44 indexed citations

6.

Mackey, Mark, et al.. (2006). Molecular Field Extrema as Descriptors of Biological Activity: Definition and Validation. Journal of Chemical Information and Modeling. 46(2). 665–676. 311 indexed citations

7.

Mackey, Mark, et al.. (2004). Peptides to non-peptides: leads from structureless virtual screening. 2(2). 57–60. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact